scholarly journals Defective RAB1B-related megakaryocytic ER-to-Golgi transport in RUNX1 haplodeficiency: impact on von Willebrand factor

2018 ◽  
Vol 2 (7) ◽  
pp. 797-806 ◽  
Author(s):  
Gauthami Jalagadugula ◽  
Lawrence E. Goldfinger ◽  
Guangfen Mao ◽  
Michele P. Lambert ◽  
A. Koneti Rao

Key Points GTPase RAB1B is a direct transcriptional target of RUNX1 in MK/platelets and is downregulated in RUNX1 haplodeficiency. RUNX1 downregulation is associated with defective RAB1B-related ER-to-Golgi transport and alterations in α-granule vWF.

Blood ◽  
2016 ◽  
Vol 128 (2) ◽  
pp. 277-285 ◽  
Author(s):  
Mafalda Lopes da Silva ◽  
Daniel F. Cutler

Key Points The 3 endothelial secretory pathways—constitutive, basal, and regulated—release VWF in different multimeric states. Apical- and basolaterally-released VWF follow different secretory pathways, thus releasing differentially multimerized protein.


2019 ◽  
Vol 3 (24) ◽  
pp. 4147-4154 ◽  
Author(s):  
Ferdows Atiq ◽  
Lisette M. Schütte ◽  
Agnes E. M. Looijen ◽  
Johan Boender ◽  
Marjon H. Cnossen ◽  
...  

Key Points VWF and FVIII levels after desmopressin, which mimic hemostatic response, are associated with the bleeding phenotype of type 1 VWD patients. Variability in VWF and FVIII response to hemostatic challenges may partly explain heterogeneity in bleeding phenotype of VWD patients.


Blood ◽  
2013 ◽  
Vol 122 (6) ◽  
pp. 1042-1051 ◽  
Author(s):  
Ines Brandherm ◽  
Jennifer Disse ◽  
Dagmar Zeuschner ◽  
Volker Gerke

Key Points A calcineurin-like phosphatase dephosphorylates annexin A2 in the course of cAMP-induced Weibel-Palade body exocytosis. Dephosphorylation at serine 11 of annexin A2 triggers complex formation with S100A10 that is required for von Willebrand factor secretion.


Blood ◽  
2016 ◽  
Vol 127 (5) ◽  
pp. 637-645 ◽  
Author(s):  
Dominic W. Chung ◽  
Junmei Chen ◽  
Minhua Ling ◽  
Xiaoyun Fu ◽  
Teri Blevins ◽  
...  

Key Points High-density lipoprotein and its major apolipoprotein ApoA-I prevent von Willebrand factor self-association. Targeting von Willebrand factor self-association could be a new approach to treating thrombotic disorders.


Blood ◽  
2015 ◽  
Vol 126 (20) ◽  
pp. 2338-2341 ◽  
Author(s):  
Qi Da ◽  
Miho Teruya ◽  
Prasenjit Guchhait ◽  
Jun Teruya ◽  
John S. Olson ◽  
...  

Key Points Extracellular Hb alters the GPIbα-VWF interaction.


Blood ◽  
2016 ◽  
Vol 128 (1) ◽  
pp. 110-119 ◽  
Author(s):  
Vikram G. Pillai ◽  
Jialing Bao ◽  
Catherine B. Zander ◽  
Jenny K. McDaniel ◽  
Palaniappan S. Chetty ◽  
...  

Key Points HNPs inhibit proteolytic cleavage of VWF by ADAMTS13 by physically blocking VWF-ADAMTS13 interactions. Plasma levels of HNP1, HNP2, and HNP3 are markedly increased in patients with acquired autoimmune TTP.


Blood ◽  
2013 ◽  
Vol 121 (14) ◽  
pp. 2762-2772 ◽  
Author(s):  
Jiong-Wei Wang ◽  
Eveline A. M. Bouwens ◽  
Maria Carolina Pintao ◽  
Jan Voorberg ◽  
Huma Safdar ◽  
...  

Key Points Isolation of BOECs from multiple patients with VWD is feasible, and the study of BOECs helps explain the pathogenic complexity of VWD. Abnormalities in WPB biogenesis and exocytosis and defects in VWF string formation correlate with the phenotypic features of patients with VWD.


Blood ◽  
2014 ◽  
Vol 124 (5) ◽  
pp. e1-e3 ◽  
Author(s):  
Adrienne Lee ◽  
Gary Sinclair ◽  
Karen Valentine ◽  
Paula James ◽  
Man-Chiu Poon

Key Points Remission status in relapsing-remitting AVWS depends on the balance of VWF clearance by anti-VWF antibody and VWF secretion. VWFpp:Ag ratio is a simple assay that provides information on this balance and predicts remission status in this case of AVWS.


Blood ◽  
2014 ◽  
Vol 123 (14) ◽  
pp. 2153-2156 ◽  
Author(s):  
Agon Hyseni ◽  
Hans Kemperman ◽  
Dylan W. de Lange ◽  
Jozef Kesecioglu ◽  
Philip G. de Groot ◽  
...  

Key Points von Willebrand factor in its glycoprotein Ib conformation predicts 28-day mortality and could be a useful addition to the APACHE-IV score.


Blood ◽  
2014 ◽  
Vol 123 (1) ◽  
pp. 121-125 ◽  
Author(s):  
Julie Rayes ◽  
Lubka T. Roumenina ◽  
Jordan D. Dimitrov ◽  
Yohann Repessé ◽  
Mathieu Ing ◽  
...  

Key Points Complement factor H and von Willebrand factor colocalize in the Weibel-Palade bodies of endothelial cells and interact in normal plasma. Formation of the complex enhances FH cofactor activity and VWF-mediated platelet aggregation.


Sign in / Sign up

Export Citation Format

Share Document